Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Non-Anticoagulant Rodenticides Market worth $1.43 billion by 2030 - Exclusive Report by MarketsandMarkets™

This image opens in the lightbox

News provided by

MarketsandMarkets

17 Dec, 2025, 11:59 GMT

Share this article

Share toX

Share this article

Share toX

DELRAY BEACH, Fla., Dec. 17, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the non-anticoagulant rodenticides market is projected to grow from USD 1.11 billion in 2025 and to reach USD 1.43 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Browse 150 market data Tables and 75 Figures spread through 210 Pages and in-depth TOC on 'Non-Anticoagulant Rodenticides Market - Global Forecast to 2030'

Non-Anticoagulant Rodenticides Market Size & Forecast

  • Market Size Available for Years: 2020–2030
  • 2025 Market Size: USD 1.11 billion
  • 2030 Projected Market Size: USD 1.43 billion
  • CAGR (2025–2030): 5.2%

Non-Anticoagulant Rodenticides Market Trends & Insights:

  • Market growth is driven by regulatory restrictions on anticoagulants, rising rodent resistance, and the broader adoption of integrated pest management strategies worldwide.
  • Zinc phosphide holds a significant market share in the type segment.
  • The pellets segment holds a significant market share in the mode of application segment.
  • The spray segment is estimated to be the fastest growing, with a CAGR of 6.7%.
  • North America holds a significant share in the non-anticoagulant rodenticides market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13299457

The non-anticoagulant rodenticides market is experiencing a rise in demand driven by rodent resistance to anticoagulants and stricter regulatory restrictions on traditional rodenticides. Growth in urbanization, food-processing, and agriculture is increasing the need for fast-acting, effective rodent control solutions. Products such as zinc phosphide, bromethalin, and cholecalciferol are preferred for their rapid action and lower risk of secondary poisoning. Additionally, food safety and environmental regulations are accelerating the adoption of low-residue, eco-friendly formulations. Market expansion is further supported by technological innovations such as microencapsulation, high-palatability baits, and sensor-integrated smart baiting systems, which enhance effectiveness while minimizing non-target exposure. These factors collectively drive growth across urban, industrial, and agricultural sectors globally.

Zinc phosphide holds a significant market share in the type segment.

Zinc phosphide type holds a significant share in the type segment of the non-anticoagulant rodenticides market due to its proven efficacy and widespread availability. It commands a major share in the type segment owing to its high efficacy, rapid action, and cost efficiency. It is extensively utilized across agriculture, food storage, and urban pest management for controlling rodent populations. Zinc phosphide is favored over other non-anticoagulants due to its ability to deliver rapid mortality, minimize bait aversion, and reduce crop or product losses. Its versatility in bait formulations and widespread availability further strengthen its market position. Moreover, increasing rodent resistance to anticoagulants and tightening regulatory restrictions on conventional rodenticides are driving the adoption of zinc phosphide-based solutions, reinforcing its dominance in the segment. Key players in the non-anticoagulant rodenticide market include BASF (Germany), Sumitomo Chemical (Japan), UPL Ltd./Arysta LifeScience (India), Bell Laboratories, Inc. (US), PCT Rural (Australia), and other players.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=13299457

The pellets segment holds a significant market share in the mode of application segment.

Pellets hold a significant market share in the mode of application segment of the non-anticoagulant rodenticides market due to their effectiveness, ease of use, and versatility. Pellets are preferred for their ease of handling, accurate dosing, and high palatability to rodents, ensuring effective control in both urban and agricultural settings. They are widely used with zinc phosphide, bromethalin, and cholecalciferol formulations, providing rapid and targeted rodent management. Additionally, pellets offer enhanced stability and longer shelf life compared to liquid or powder forms, improving operational efficiency for pest control operators. The segment's prominence is further reinforced by integration into automated baiting systems and IPM programs, making pellets the dominant application mode in the non-anticoagulant rodenticides market.

Based on region, North America holds a significant share in the non-anticoagulant rodenticides market.

North America holds a significant share of the non-anticoagulant rodenticides market, driven by increasing rodent resistance to anticoagulants, stringent regulatory and food safety requirements, and strong adoption of acute toxicants such as zinc phosphide, bromethalin, and cholecalciferol. The region's large urban centers, extensive food-processing facilities, and agricultural operations further contribute to the demand for rapid and effective rodent control solutions. Moreover, the presence of major industry players and advanced pest management technologies, including pellet formulations and smart baiting systems, reinforces North America's leading position in this market segment.

Top Companies in the Non-Anticoagulant Rodenticides Market

The report profiles key players such as BASF (Germany), Sumitomo Chemical (Japan), UPL Ltd (India), Bell Laboratories, Inc. (US), PCT Rural (Australia), Animal Control Technologies (Australia), Imtrade CropScience (Australia), Rentokil Initial plc (UK), AG Schilling & Co (Germany), 4Farmers Australia (Australia), Farmalynx Pty Ltd (Australia), Zagro (Malaysia), JT Eaton & Co., Inc. (USA), Neogen Technologies (USA), and Liphatech, Inc. (US). These companies are actively engaged in manufacturing and supplying zinc phosphide, bromethalin, cholecalciferol, and other non-anticoagulant rodenticides across agricultural, urban, and industrial sectors globally.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=13299457

Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting

Related Reports:

Rodenticides Market by Type (Chemical, Mechanical, Biological, And Software & Services), Mode of Application (Pellets, Spray, And Powder), End Use (Agriculture, Warehouses, Urban Centers), Rodent Type, and Region-Global Forecast to 2029

Pest Control Market by Control Method (Chemical, Mechanical, Biological, Software & Services), Pest Type (Insects, Rodents, Termites, Wildlife), Mode of Application (Sprays, Traps, Baits, Pellets, Powder), Application and Region - Global Forecast to 2028

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar

MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/non-anticoagulant-rodenticides-companies.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/non-anticoagulant-rodenticides.asp

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Modal title

Also from this source

Lay-up Composites Market worth $72.87 billion by 2030 - Exclusive Report by MarketsandMarkets™

Lay-up Composites Market worth $72.87 billion by 2030 - Exclusive Report by MarketsandMarkets™

According to MarketsandMarkets, the report "Lay-up Composites Market by Fiber Type (Glass Fiber Composites, Carbon Fiber Composites, Natural Fiber...

Healthcare Digital Signage Market worth $1.10 billion by 2030 - Exclusive Report by MarketsandMarkets™

Healthcare Digital Signage Market worth $1.10 billion by 2030 - Exclusive Report by MarketsandMarkets™

According to MarketsandMarkets™, the Healthcare Digital Signage Market is expected to reach USD 1.10 billion by 2030, up from USD 0.75 billion in...

More Releases From This Source

Explore

Chemical

Chemical

Chemical

Chemical

Agriculture

Agriculture

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.